Ecoeos answers the question of who is at risk from environmental toxins and how people can protect themselves and their families.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location San Francisco, CA, USA
  • Currency USD
  • Founded July 2010
  • Employees 3
  • Website

Company Overview

Ecoeos develops clinically-validated DNA tests to measure personal susceptibiilty to environmental toxins. Ecoeos' first product is a mail-in genetic test that reveals a person's mercury susceptibility. Mercury, a vile neurotoxin, can harm developing fetuses and children. Future products focus on toxins such as lead and pesticides. Surveys (N=1,100) indicate early adopters are 15M women of reproductive age who are environmentally sensitive.

Management Team

  • Founder Signum Biosciences, Founder, Program on Medicine & Technology at UCLA's Medical School. PhD Biophysics, Johns Hopkins; MBA, Harvard, best selling author

  • CEO, Napo Pharmaceuticals, CEO, Shaman Pharmaceuticals.
    BS, Pharmacology, UCSD, MBA, Dartmouth

  • Award-winning journalist (NYTs, NPR, Fortune) and bestselling author. Founding Director of the Center for Life Science Policy, UC Berkeley

  • Led product launches at GSK, Wyeth, Chevrolet, Zoomerang, Healthline and Wageworks. Degree in Marketing Metrics, Wharton

  • Experienced in consumer and web product development. Completed major projects for Mayo Clinic, Philips, HP, Razorfish, Hasbro, and Schick.
    BFA, University of Washington


Matthew Rossiter, Fenwick and West

Previous Investors

Various angel investors